Maternal medication and herbal use and risk for hypospadias: data from the National Birth Defects Prevention Study, 1997–2007
Jennifer N. Lind(Centers for Disease Control and Prevention), Samantha E. Parker(Boston University), Sarah C. Tinker(Centers for Disease Control and Prevention), Jennita Reefhuis(Centers for Disease Control and Prevention), Margaret A. Honein(National Center on Birth Defects and Developmental Disabilities), Cheryl S. Broussard(Centers for Disease Control and Prevention), Martha M. Werler(Boston University), Suzan L. Carmichael(Stanford Medicine), Richard S. Olney(University of Iowa)
Cited by 69
Related Papers
H1N1 2009 influenza virus infection during pregnancy in the USA
|The Lancet|2009|1.4k
Birth Defects Among Fetuses and Infants of US Women With Evidence of Possible Zika Virus Infection During Pregnancy
|JAMA|2016|781
Guidelines for case classification for the national birth defects prevention study
|Birth Defects Research Part A Clinical and Molecular Teratology|2003|582
Sickle Hemoglobin (Hb S) Allele and Sickle Cell Disease: A HuGE Review
|American Journal of Epidemiology|2000|535
Use of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth Defects
|New England Journal of Medicine|2007|501